IP Verse

Methods And Compositions For Delivering Mrna Coded Antibodies - EP2970456B1

PatentPatent Analysis

EP2970456

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP14717945A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Apr 16, 2021
Grant Date
May 19, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2858679B2
EP3626258B1
EP3103469B1

Bibliography

The patent EP2970456B1 was granted to Shire Human Genetic Therapies on May 19, 2021 following the initial filing on Mar 14, 2014 under the application number EP14717945A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EIPFeb 21, 2022ADMISSIBLE
STRAWMANFeb 18, 2022ADMISSIBLE
WITHERS & ROGERSFeb 18, 2022ADMISSIBLE
GLAXOSMITHKLINEFeb 18, 2022WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents